|
1
|
Lajeunesse D, MartelPelletier J, Fernandes
JC, Laufer S and Pelletier JP: Treatment with licofelone prevents
abnormal subchondral bone cell metabolism in experimental dog
osteoarthritis. Ann Rheum Dis. 63:78–83. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jüni P, Reichenbach S and Dieppe P:
Osteoarthritis: Rational approach to treating the individual. Best
Pract Res Clin Rheumatol. 20:721–740. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Loeser RF, Goldring SR, Scanzello CR and
Goldring MB: Osteoarthritis: A disease of the joint as an organ.
Arthritis Rheum. 64:1697–1707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mobasheri A: Osteoarthritis year 2012 in
review: Biomarkers. Osteoarthritis Cartilage. 20:1451–1464. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Daans M, Lories RJ and Luyten FP: Dynamic
activation of bone morphogenetic protein signaling in
collagen-induced arthritis supports their role in joint homeostasis
and disease. Arthritis Res Ther. 10:R1152008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Loeser RF: Molecular mechanisms of
cartilage destruction in osteoarthritis. J Musculoskelet Neuronal
Interact. 8:303–306. 2008.PubMed/NCBI
|
|
7
|
Loeser RF: Molecular mechanisms of
cartilage destruction: Mechanics, inflammatory mediators, and aging
collide. Arthritis Rheum. 54:1357–1360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hochberg MC, Altman RD, Brandt KD, Clark
BM, Dieppe PA, Griffin MR, Moskowitz RW and Schnitzer TJ:
Guidelines for the medical management of osteoarthritis. Part I.
Osteoarthritis of the hip. American College of Rheumatology.
Arthritis Rheu. 38:1535–1540. 1995. View Article : Google Scholar
|
|
9
|
Vane JR and Botting RM: The mechanism of
action of aspirin. Thromb Res. 110:255–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi JH, Choi JH, Kim DY, Yoon JH, Youn
HY, Yi JB, Rhee HI, Ryu KH, Jung K, Han CK, et al: Effects of SKI
306X, a new herbal agent, on proteoglycan degradation in cartilage
explant culture and collagenase-induced rabbit osteoarthritis
model. Osteoarthritis Cartilage. 10:471–478. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carbone LD, Tylavsky FA, Cauley JA, Harris
TB, Lang TF, Bauer DC, Barrow KD and Kritchevsky SB: Association
between bone mineral density and the use of nonsteroidal
anti-inflammatory drugs and aspirin: Impact of cyclooxygenase
selectivity. J Bone Miner Res. 18:1795–1802. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bauer DC, Orwoll ES, Fox KM, Vogt TM, Lane
NE, Hochberg MC, Stone K and Nevitt MC: Aspirin and NSAID use in
older women: Effect on bone mineral density and fracture risk.
Study of Osteoporotic Fractures Research Group. J Bone Miner Res.
11:29–35. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vestergaard P, Rejnmark L and Mosekilde L:
Fracture risk associated with use of nonsteroidal anti-inflammatory
drugs, acetylsalicylic acid, and acetaminophen and the effects of
rheumatoid arthritis and osteoarthritis. Calcif Tissue Int.
79:84–94. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pritzker KP: Osteoarthritis: Joint
instability and OA: Do animal models provide insights? Nat Rev
Rheumatol. 7:444–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tochigi Y, Vaseenon T, Heiner AD,
Fredericks DC, Martin JA, Rudert MJ, Hillis SL, Brown TD and
McKinley TO: Instability dependency of osteoarthritis development
in a rabbit model of graded anterior cruciate ligament transection.
J Bone Joint Surg Am. 93:640–647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshioka M, Coutts RD, Amiel D and Hacker
SA: Characterization of a model of osteoarthritis in the rabbit
knee. Osteoarthritis Cartilage. 4:87–98. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pelletier JP, Jovanovic D, Fernandes JC,
Manning P, Connor JR, Currie MG, Di Battista JA and
Martel-Pelletier J: Reduced progression of experimental
osteoarthritis in vivo by selective inhibition of inducible nitric
oxide synthase. Arthritis Rheum. 41:1275–1286. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bijlsma JW, Berenbaum F and Lafeber FP:
Osteoarthritis: An update with relevance for clinical practice.
Lancet. 377:2115–2126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pelletier JP, DiBattista JA, Raynauld JP,
Wilhelm S and Martel-Pelletier J: The in vivo effects of
intraarticular corticosteroid injections on cartilage lesions,
stromelysin, interleukin-1, and oncogene protein synthesis in
experimental osteoarthritis. Lab Invest. 72:578–586.
1995.PubMed/NCBI
|
|
20
|
Pelletier JP, Mineau F, Raynauld JP,
Woessner JF Jr, Gunja-Smith Z and Martel-Pelletier J:
Intraarticular injections with methylprednisolone acetate reduce
osteoarthritic lesions in parallel with chondrocyte stromelysin
synthesis in experimental osteoarthritis. Arthritis Rheum.
37:414–423. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ruggeri R, Pulsatelli L, Melchiorri C, Da
Re R, Focherini MC, Veronesi M and Facchini A: Differential
expression of IL-1 and TNF receptors in inflammatory arthritis and
osteoarthritis. Boll Soc Ital Biol Sper. 72:15–20. 1996.PubMed/NCBI
|
|
22
|
Attur MG, Patel IR, Patel RN, Abramson SB
and Amin AR: Autocrine production of IL-1 beta by human
osteoarthritis-affected cartilage and differential regulation of
endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc
Assoc Am Physicians. 110:65–72. 1998.PubMed/NCBI
|
|
23
|
Needleman P and Manning PT: Interactions
between the inducible cyclooxygenase (COX-2) and nitric oxide
synthase (iNOS) pathways: Implications for therapeutic intervention
in osteoarthritis. Osteoarthritis Cartilage. 7:367–370. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou JL, Fang HS, Peng H, Hu QJ, Liu SQ,
Ming JH and Qiu B: PKCa agonists enhance the protective effect of
hyaluronic acid on nitric oxide-induced apoptosis of articular
chondrocytes in vitro. Iran J Basic Med Sci. 16:1276–1281.
2013.PubMed/NCBI
|
|
25
|
Tripathi P, Tripathi P, Kashyap L and
Singh V: The role of nitric oxide in inflammatory reactions. FEMS
Immunol Med Microbiol. 51:443–452. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Naito K, Takahashi M, Kushida K, Suzuki M,
Ohishi T, Miura M, Inoue T and Nagano A: Measurement of matrix
metalloproteinases (MMPs) and tissue inhibitor of
metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis:
Comparison with generalized osteoarthritis. Rheumatology (Oxford).
38:510–515. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Murphy G, Knäuper V, Atkinson S, Butler G,
English W, Hutton M, Stracke J and Clark I: Matrix
metalloproteinases in arthritic disease. Arthritis Res. 4(Suppl 3):
S39–S49. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kusano K, Miyaura C, Inada M, Tamura T,
Ito A, Nagase H, Kamoi K and Suda T: Regulation of matrix
metalloproteinases (MMP-2,-3,-9, and-13) by Interleukin-1 and
interleukin-6 in mouse calvaria: Association of MMP induction with
bone resorption. Endocrinology. 139:1338–1345. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Inada M, Wang Y, Byrne MH, Rahman MU,
Miyaura C, López-Otín C and Krane SM: Critical roles for
collagenase-3 (Mmp13) in development of growth plate cartilage and
in endochondral ossification. Proc Natl Acad Sci USA.
101:17192–17197. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Knäuper V, Bailey L, Worley JR, Soloway P,
Patterson ML and Murphy G: Cellular activation of proMMP-13 by
MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett.
532:127–130. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Konttinen YT, Ainola M, Valleala H, Ma J,
Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, López-Otín C
and Takagi M: Analysis of 16 different matrix metalloproteinases
(MMP-1 to MMP-20) in the synovial membrane: Different profiles in
trauma and rheumatoid arthritis. Ann Rheum Dis. 58:691–697. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Itoh T, Uzuki M, Shimamura T and Sawai T:
Dynamics of matrix metalloproteinase (MMP)-13 in the patients with
rheumatoid arthritis. Ryumachi. 42:60–69. 2002.(In Japanese).
PubMed/NCBI
|
|
33
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gilbert SJ, Blain EJ, AlSabah A, Zhang Y,
Duance VC and Mason DJ: Protein kinase R plays a pivotal role in
oncostatin M and interleukin-1 signalling in bovine articular
cartilage chondrocytes. Eur Cell Mater. 23:41–57. 2012.PubMed/NCBI
|
|
35
|
Dean DD and Woessner JF Jr: Extracts of
human articular cartilage contain an inhibitor of tissue
metalloproteinases. Biochem J. 218:277–280. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Heard BJ, Martin L, Rattner JB, Frank CB,
Hart DA and Krawetz R: Matrix metalloproteinase protein expression
profiles cannot distinguish between normal and early osteoarthritic
synovial fluid. BMC Musculoskelet Disord. 13:1262012. View Article : Google Scholar : PubMed/NCBI
|
